PlainPharmaWatch

CMS Open Payments · Program Year 2024

Texas

Texas received $224,714,621.51 in pharmaceutical-industry payments to 58,838 physicians and 87 teaching hospitals across 1,485,278 transactions.

$224.7M
Total payments
$184.6M
To physicians
$19.4M
To teaching hospitals
#5
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $224.7M in payments to 58,838 physicians and 87 teaching hospitals in Texas. That ranks Texas #5 of 59 states and territories (1.6% of the US total), averaging $3.1K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Texas pairs top-10% payment volume with a physician-heavy payment mix.

#5
of 59 states
1.6%
of the national total
82.1%
to physicians vs. hospitals
58,838
physicians paid

What the Data Shows for Texas

Texas sits in the high-volume tercile at #5 of 59 by all-tracks dollars (1.6% of the US total): $224,714,621.51 across 1,485,278 PY2024 transactions.

Physician versus hospital mix is near the corpus middle (82.1% / 8.6%). Average transaction $151.29. Leading nature of payment: "Compensation for Services Other Than Consulting" at $52.4M (23.3% of the state file; top-three natures 60.5%).

Texas sits in the 93rd percentile (top-10 nationally). Just above: Massachusetts ($230.3M). Just below: New York ($216.8M). For context: top-ranked California ($342.4M) is 1.5× larger than Texas. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Texas are distributed between physicians and teaching hospitals.

Physician Payments

$184.6M

82.1% of total · 58,838 recipients · $3.1K avg

Teaching Hospital Payments

$19.4M

8.6% of total · 87 hospitals · $222.8K avg

Payment Breakdown by Type

Texas has 16 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 23.3%.

Nature concentration in Texas

Top three Open Payments natures are 60.5% of state dollars; residual is every other reported nature

Compensation for Services Ot…$52.4MRoyalty or License$42.4MConsulting Fee$41.1MAll other natures (13)$88.8M

Payment categories in Texas

Top categories by total reported dollar volume

1. Compensation for Services…$52.4M2. Royalty or License$42.4M3. Consulting Fee$41.1M4. Food and Beverage$39.5M5. Travel and Lodging$18.5M6. Education$6.0M7. Debt Forgiveness$5.7M8. Grant$4.3M9. Honoraria$4.0M10. Long-Term Medical Supply…$3.8M
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $52.4M 21,433
Royalty or License $42.4M 1,154
Consulting Fee $41.1M 15,969
Food and Beverage $39.5M 1,369,541
Travel and Lodging $18.5M 54,548
Education $6.0M 13,875
Debt Forgiveness $5.7M 782
Grant $4.3M 280
Honoraria $4.0M 1,540
Long-Term Medical Supply or Device Loan $3.8M 1,758
Compensation for Faculty or Speaker (Medical Education) $2.8M 1,142
Space Rental or Facility Fees $2.5M 363
Acquisitions $753.2K 46
Gift $501.8K 2,220
Charitable Contribution $199.7K 17
Entertainment $53.8K 610

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Texas totals can and cannot tell you

The aggregate payment figure for Texas measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Texas's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.